Wealth Science Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Wealth Science Advisors's ABBV Position: Q3 2026 in Review
Wealth Science Advisors reduced its AbbVie (ABBV) stake by 4% in Q3 2026, selling an estimated $33.3K and leaving 3,090 shares worth $808K. The position accounts for 0.34% of the portfolio, ranked #39.
Wealth Science Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $810K in Q2 2026. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Wealth Science Advisors held 3,090 shares of AbbVie worth $808K as of Q3 2026.
- Wealth Science Advisors sold 130 AbbVie shares in Q3 2026, an estimated $33.3K.
- AbbVie made up 0.34% of Wealth Science Advisors's portfolio in Q3 2026, its #39 holding.
- Wealth Science Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- Wealth Science Advisors's AbbVie position peaked at $810K in Q2 2026.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.